Project Oncology®

173 Avsnitt

1. Highlighting the Current Status and Future of Theranostics

   Publicerades: 2024-06-28
2. Diving into New Directions of Radiopharmaceuticals

   Publicerades: 2024-06-28
3. AI in Nuclear Medicine: Improvements in the Field

   Publicerades: 2024-06-28
4. A Look at the Horizon of Cancer Vaccines

   Publicerades: 2024-06-20
5. MCED Testing: Strategies for Mitigating the Risk of Overdiagnosis

   Publicerades: 2024-06-20
6. A Unique Look at the Current and Future Directions of Cancer Vaccines

   Publicerades: 2024-06-20
7. The Impact of Advocacy on Healthcare

   Publicerades: 2024-06-14
8. Updates on New Technologies and Imaging Agents in Healthcare

   Publicerades: 2024-06-14
9. The Power of Patient Advocacy in Daily Clinical Practice

   Publicerades: 2024-06-14
10. Practical Applications for Quality Improvement in Myelofibrosis Management: A Video Brief on Lessons Learned

    Publicerades: 2024-06-12
11. A Pre-Conference Perspective of SNMMI 2024

    Publicerades: 2024-06-06
12. An Introduction to Squamous Cell Carcinoma of the Head and Neck

    Publicerades: 2024-06-06
13. EMERALD Trial: An Analysis of Key Biomarkers and Patient Subgroups

    Publicerades: 2024-05-31
14. Poster Pearl: A 2-Biomarker Class MCED Test Delivers High Specificity and Sensitivity

    Publicerades: 2024-05-23
15. Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer

    Publicerades: 2024-05-09
16. The Role of Immunotherapy in the Treatment of Recurrent or Metastatic HNSCC: The Evidence

    Publicerades: 2024-05-03
17. Current and Emerging Biomarkers of Response to Immunotherapeutic Regimens

    Publicerades: 2024-05-03
18. Managing Immune-Related Adverse Events With Immunotherapies

    Publicerades: 2024-05-03
19. Optimizing First-Line Immunotherapy for Recurrent or Metastatic HNSCC

    Publicerades: 2024-05-03
20. Overcoming Barriers to Equitable Care in HNSCC

    Publicerades: 2024-05-03